Overview
Junichi Ota practices practicing medicine in Yokohama, Japan.
His clinical expertise encompasses Lung Metastases, Intussusception in Children, Renal Cell Carcinoma (RCC), and Lithotripsy.
He is actively involved in clinical research, co-authoring 11 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Junichi Ota
Is Junichi Ota a top-rated expert for Lithotripsy?
MediFind is an objective health platform that identifies experts based on real-world data. Junichi Ota is classified as an Experienced expert for Lithotripsy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Junichi Ota participate in research or clinical trials?
Yes. Junichi Ota has published 11 articles and abstracts on conditions like Lithotripsy. You can view a list of Junichi Ota's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Intussusception in ChildrenMr. Ota isExperienced. Learn about Intussusception in Children.
- LithotripsyMr. Ota isExperienced. Learn about Lithotripsy.
- Lung MetastasesMr. Ota isExperienced. Learn about Lung Metastases.
- Renal Cell Carcinoma (RCC)Mr. Ota isExperienced. Learn about Renal Cell Carcinoma (RCC).